Astec Lifesciences Rights Issue 2025 vs Bodhtree Consulting Rights Issue 2025

Comparison between Astec Lifesciences Rights Issue 2025 and Bodhtree Consulting Rights Issue 2025.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Astec Lifesciences Rights Issue 2025 and Bodhtree Consulting Rights Issue 2025. Astec Lifesciences Rights Issue 2025 is listed on BSE, NSE while Bodhtree Consulting Rights Issue 2025 is listed on BSE.

 Astec Lifesciences LimitedBodhtree Consulting Ltd
LogoAstec Lifesciences Rights Issue 2025 LogoBodhtree Consulting Rights Issue 2025 Logo
Listing AtBSE, NSEBSE
Terms of Payment

Issue Price of Rs 890/- per share is payable at the time of Application in the Rights Issue.

The full amount of the Issue Price being ₹ 30/- will be payable on application.

Entitlement1 Rights Equity Share(s) for every 7 fully paid-up Equity Shares held on Record Date4 Rights Equity Share(s) for every 1 fully paid-up Equity Shares held on Record Date
Application FormApplication Form Application Form
Letter of Offer Letter of Offer Letter of Offer
RegistrarMUFG Intime India Pvt.Ltd.Bigshare Services Pvt.Ltd.
Lead Managers

Rights Issue Size and Price

The issue size of Astec Lifesciences Rights Issue 2025 rights issue is ₹249.35 Crores, whereas Bodhtree Consulting Rights Issue 2025 rights issue size is ₹14.08 Crores.

 Astec Lifesciences LimitedBodhtree Consulting Ltd
Issue Size28,01,673 shares46,92,456 shares
Issue Size (Amount)₹249.35 Crores₹14.08 Crores
Issue Price₹890 per share₹30 per share
Face Value₹10 per share₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Astec Lifesciences Rights Issue 2025 is Jul 04, 2025 while record date of Bodhtree Consulting Rights Issue 2025 is Jun 28, 2025.

 Astec Lifesciences LimitedBodhtree Consulting Ltd
Record DateJul 04, 2025Jun 28, 2025
Credit of Rights EntitlementsJul 07, 2025Jul 02, 2025
Bid/Offer Opens OnJul 14, 2025Jul 07, 2025
Renunciation of Rights EntitlementsJul 22, 2025Jul 21, 2025
Bid/Offer Closes OnJul 28, 2025Jul 24, 2025
Deemed Date of AllotmentJul 29, 2025Jul 25, 2025
Credit DateJul 30, 2025Jul 28, 2025
Listing DateAug 01, 2025Jun 28, 2025

Financials details

Comparison of Astec Lifesciences Rights Issue 2025 and Bodhtree Consulting Rights Issue 2025 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

 Astec Lifesciences LimitedBodhtree Consulting Ltd
Financial

Astec Lifesciences Limited Financial Information (Restated Consolidated)

Astec Lifesciences Limited's revenue decreased by 17% and profit after tax (PAT) dropped by 187% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Revenue381.30458.18
Profit After Tax-134.71-46.89
Net Worth234.75369.29
Reserves and Surplus215.13349.68
Amount in ₹ Crore

Bodhtree Consulting Ltd Financial Information (Restated)

Bodhtree Consulting Ltd's revenue decreased by 63% and profit after tax (PAT) rose by 49% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Revenue6.0716.56
Profit After Tax-1.27-2.46
Reserves and Surplus-3.61-2.55
Amount in ₹ Crore

Compare with others

Compare: